Health product recalls and alerts, 2005
148 notices, newest first. Each links to the official notice.
Drugs, vaccines and biologics
- Archive – Health Canada Advises Consumers not to use Kaizen Ephedrine HCL Tablets for Weight LossDecember 28, 2005 · Drugs
- Archive – Health Canada Advises Consumers to be Cautious when Buying Tamiflu OnlineDecember 23, 2005 · Drugs
- Archived - Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy - For the Public - GlaxoSmithKline Inc.December 22, 2005 · Drugs
- Association of PrAvandia® (rosiglitazone) and PrAvandamet® (rosiglitazone/metformin) with new onset and/or worsening of macular edema - For the PublicDecember 21, 2005 · Drugs
- Association of Avandia (rosiglitazone) and Avandamet (rosiglitazone/metformin) with new onset and/or worsening of macular edema - For Health ProfessionalsDecember 21, 2005 · Drugs
- Archived - Association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia - For the public - Bristol-Myers Squibb CanadaDecember 20, 2005 · Drugs
- Association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia - For Health Professionals - Bristol-Myers Squibb CanadaDecember 20, 2005 · Drugs
- Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy - For Health Professionals - GlaxoSmithKline Inc.December 16, 2005 · Drugs
- Archive – Health Canada Prohibits Sale of Bextra in CanadaDecember 16, 2005 · Drugs
- Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions - Berlex Canada Inc.December 7, 2005 · Biologic or vaccine
- Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions- Notice to Hospitals- Berlex Canada Inc.December 7, 2005 · Biologic or vaccine
- Archive – Health Canada Warns Consumers to Return Bottles of Euro-ASA 80 mg Chewable Tablets to Place of PurchaseDecember 2, 2005 · Drugs · Labelling
- Archive – Health Canada Clarification on Status of Evra Contraceptive Skin Patch in CanadaNovember 28, 2005 · Drugs · Labelling
- Archived – Important Safety Information on the Association of Aranesp® (darbepoetin alfa) with pure red cell aplasiaNovember 25, 2005 · Biologic or vaccine
- Important Safety Information on the Association of Aranesp (darbepoetin alfa) with pure red cell aplasia - For Health ProfessionalsNovember 25, 2005 · Biologic or vaccine
- Archived - Important Safety Information on the contraindication of PrFEMARAFootnote *November 24, 2005 · Drugs
- Important Safety Information on the discontinuation of Climacteron Injection (estradiol dienanthate, estradiol benzoate and testosterone enanthate benzilic acid hydrazone)- Sandoz Canada Inc. - For Health ProfessionalsNovember 23, 2005 · Drugs
- Archive – Health Canada Warns Consumers Not to Use a Certain Lot of Aquify 2-mL Long-Lasting Comfort Drops Due to Potential Health RiskNovember 18, 2005 · Drugs · Contamination
- Important Safety Information on the contraindication of Femara (letrozole) in premenopausal women - For Health ProfessionalsNovember 17, 2005 · Drugs
- Archived - Association of Gamunex (Immune globulin intravenous [Human] 10%) with hemolytic reactionsOctober 19, 2005 · Biologic or vaccine
- Association of Gamunex (Immune globulin intravenous [Human] 10%) with hemolytic reactions- Notice to Hospitals - Bayer Inc.October 19, 2005 · Biologic or vaccine
- Important Safety Information on Flomax (tamsulosin) and Intraoperative Floppy Iris Syndrome (IFIS)-Boehringer Ingelheim (Canada) Ltd.October 14, 2005 · Drugs
- Archived - Paxil (paroxetine) and Possible Increased Risk of Birth DefectsOctober 7, 2005 · Drugs
- Archive - Safety Information about a Class of Asthma Drugs Known as Long-Acting Beta-2 AgonistsOctober 4, 2005 · Drugs
- Archived - Important Safety Information on Strattera (atomoxetine hydrochloride) and the potential for behavioral and emotional changes, including risk of self-harm - Eli Lilly Canada Inc.September 29, 2005 · Drugs
- Important Safety Information on Paxil (paroxetine) and Possible Increased Risk of Birth Defects- For Health Professionals- GlaxoSmithKline Inc.September 29, 2005 · Drugs
- Important Safety Information on Strattera (atomoxetine hydrochloride) and the potential for behavioral and emotional changes, including risk of self-harm- For Health Professionals- Eli Lilly Canada Inc.September 28, 2005 · Drugs
- Important Safety Information on Inappropriate Administration of Nimotop (Nimodipine) Capsules - Notice to hospitals - Bayer Inc.September 21, 2005 · Drugs
- Important Safety Information on Celebrex (celecoxib) - For Health Professionals - Pfizer Canada Inc.September 21, 2005 · Drugs
- Archived – Important Safety Information on DURAGESIC* (fentanyl transdermal system)September 16, 2005 · Drugs
- Important safety information on Duragesic (fentanyl transdermal system) - For Health Professionals - Janssen-Ortho Inc. - For Health ProfessionalsSeptember 13, 2005 · Drugs
- Important Safety Information on Serevent – GlaxoSmithKline Inc.September 9, 2005 · Drugs
- Important Safety Information on Oxeze (formoterol fumarate dihydrate) Turbuhaler – AstraZeneca Canada Inc. – For Health ProfessionalsSeptember 9, 2005 · Drugs · Product safety
- Important Safety Information on Foradil (formoterol fumarate) – Novartis Pharmaceuticals Canada Inc. – For Health ProfessionalsSeptember 9, 2005 · Drugs · Product safety
- Important Safety Information on Thioridazine – For Health ProfessionalsSeptember 8, 2005 · Drugs · Product safety
- Archive – Sales of Anti-Psychotic Drug Thioridazine To Be StoppedSeptember 8, 2005 · Drugs
- Important Safety Information on Adderall XRSeptember 2, 2005 · Drugs · New safety information
- Archived – Important Safety Information on CELEBREXFootnote *(celecoxib) – Pfizer Canada Inc.September 1, 2005 · Drugs
- Archived - Important Safety Information on IRESSA® (gefitinib) 250 mg Tablets - AstraZeneca Canada Inc.August 26, 2005 · Drugs
- Iressa (gefitinib) 250 mg Tablets - Advisories, Warnings and Recalls for Health ProfessionalsAugust 26, 2005 · Drugs
- Important Safety Information on Albumin Therapy in Critically-ill Patients – Notice to HospitalsAugust 18, 2005 · Biologic or vaccine · Product safety
- Archive – Health Canada Advises Consumers about Recall of Counterfeit Lipitor Sold in the United KingdomAugust 15, 2005 · Drugs · Labelling
- Archived - Updated Renal Safety Information on Zometa (Zoledronic Acid) and Aclasta (Zoledronic Acid) - Novartis Pharmaceuticals Canada inc.August 9, 2005 · Drugs
- Updated Renal Safety Information on Zometa (Zoledronic Acid) and Aclasta (Zoledronic Acid) – Novartis Pharmaceuticals Canada Inc. – For Health ProfessionalsAugust 9, 2005 · Drugs
- Archive – Potentially Fatal Interaction Between Slow-Release Opioid Painkillers and AlcoholAugust 3, 2005 · Drugs
- Archived - Concomitant Use of Paxil (paroxetine hydrochloride) or Paxil CR (paroxetine hydrochloride controlled release tablets) and pimozide (Orap) Resulting in Arrhythmias (Irregular Heartbeats)July 28, 2005 · Drugs
- Archive – Health Canada Advises About Vision Problems Possibly Associated with Viagra, Cialis and LevitraJuly 26, 2005 · Drugs
- Important Safety Information on Concomitant Use of PAXIL or PAXIL CR and pimozide (Orap) – GlaxoSmithKline Inc. – For Health ProfessionalsJuly 22, 2005 · Drugs · Product safety
- New Safety Information Regarding the Co-Administration of Videx and Viread, and either Sustiva or Viramune – Bristol-Myers Squibb Canada and Gilead Sciences Inc. –- For Health ProfessionalsJuly 18, 2005 · Drugs · New safety information
- Archive – Health Canada Advises Consumers about Important Safety Information on StatinsJuly 12, 2005 · Drugs
- Potential Effect of DEPO-PROVERA (medroxyprogesterone acetate injectable suspension, USP) on Bone Mineral Density changes in adults and adolescents - Pfizer Canada Inc.July 7, 2005 · Drugs
- Archived – Reminder: Canadian Requirements for White Blood Cell Monitoring for Patients Taking Clozaril*June 30, 2005 · Drugs
- Archived - New Safety Information on the Use of DEPO-PROVERA (medroxyprogesterone acetate suspension for injection, 150 mgIM) associated with Bone Mineral Density Changes -Pfizer Canada Inc.June 30, 2005 · Drugs
- Atypical Antipsychotic Drugs and Dementia – Advisories, Warnings and Recalls for Health ProfessionalsJune 22, 2005 · Drugs · Product safety
- Archive – Health Canada Advises Consumers about Important Safety Information on Atypical Antipsychotic Drugs and DementiaJune 15, 2005 · Drugs
- Important Safety Information on the Dosage and Administration of Refludan (Lepirudin) – Berlex Canada Inc. – Notice to HospitalsJune 9, 2005 · Biologic or vaccine · Product safety
- Archive - Health Canada warns consumers not to use human growth hormone drug called GHR-15June 7, 2005 · Drugs
- Archived – Risk of Serious Allergic Reactions Following TUBERSOL [Tuberculin Purified Protein Derivative (Mantoux)] Administration – For Health ProfessionalsMay 24, 2005 · Biologic or vaccine · Product safety
- Archive – Update to April 22, 2005 Advisory Entitled: Health Canada Advises Consumers to Verify Their MedicationMay 12, 2005 · Drugs · Labelling - Product safety
- Archive – Health Canada Advises Consumers of New Warning for DIANE-35May 12, 2005 · Drugs · Labelling
- Association of Xigris (Drotrecogin Alfa Activated) with Mortality in Patients with Single Organ Dysfunction and Recent Surgery – For Health ProfessionalsMay 9, 2005 · Biologic or vaccine · Product safety
- Association of TRILEPTAL (oxcarbazepine) with Life-Threatening Dermatological Reactions and Multi-Organ Hypersensitivity – Novartis Pharmaceuticals Canada Inc. – For Health ProfessionalsApril 27, 2005 · Drugs · New safety information
- Archive– Safety Information about Elidel Cream and Protopic OintmentApril 27, 2005 · Drugs
- Association of Transdermal Drug Patches with Thermal Burns During Magnetic Resonance Imaging Procedures – Notice to HospitalsApril 26, 2005 · Drugs · Product safety
- Safety Information from Investigational Studies with REMINYL (Galantamine Hydrobromide) in Mild Cognitive Impairment – Janssen-Ortho Inc. – For Health ProfessionalsApril 22, 2005 · Drugs · Product safety
- Association of Bextra (Valdecoxib) with Serious Adverse Drug Reactions – Pfizer Canada Inc. – For Health ProfessionalsApril 22, 2005 · Drugs
- Archive – Health Canada Advises Consumers to Verify their MedicationApril 22, 2005 · Drugs · Labelling
- Health Canada Endorsed Important Safety Information Regarding ratio-Paroxetine – ratiopharm Inc. – For Health ProfessionalsApril 20, 2005 · Drugs · Labelling
- Health Canada Endorsed Important Safety Information Regarding Avandamet, Avandia, Coreg, Paxil, Paxil CR and Relafen – GlaxoSmithKline Inc. – For Health ProfessionalsApril 20, 2005 · Drugs · Product safety
- Archived – Health Canada Has Asked Pfizer to Suspend Sales of its Drug Bextra and Informs Canadians of New Restrictions on the Use of CelebrexApril 7, 2005 · Drugs
- Association of CRESTOR® (rosuvastatin) with Muscle -Related Adverse Events – AstraZeneca Canada Inc. – For Health ProfessionalsMarch 11, 2005 · Drugs · Product safety
- Archived - Association of CRESTORMarch 8, 2005 · Drugs
- Archived – Health Canada advises patients about the risks of CRESTOR® (rosuvastatin)March 3, 2005 · Drugs
- New Safety Information Regarding Fortovase and Invirase and Occurrence of Drug-Induced Hepatitis in Healthy Volunteers receiving Rifampin in combination with ritonavir boosted saquinavir.-Hoffmann-La Roche LimitedFebruary 18, 2005 · Drugs · New safety information
- Health Canada has Suspended Market Authorization of ADDERALL XR™ (Amphetamine Salts), a Drug Approved for Attention Deficit Hyperactivity Disorder (ADHD) in ChildrenFebruary 11, 2005 · Drugs · New safety information
- Association of Ezetrol (ezetimibe) with Myalgia, Rhabdomyolysis, Hepatitis, Pancreatitis, and Thrombocytopenia – Merck Frosst/Schering Pharmaceuticals – For Health ProfessionalsFebruary 4, 2005 · Drugs · New safety information
- Availability of a Revised Patient Information Leaflet for Apo-Mefloquine (Mefloquine) – Apotex Inc. – For Health ProfessionalsFebruary 3, 2005 · Drugs · New safety information
- Association of Xigris (Drotrecogin Alfa Activated) with Mortality in Patients with Single Organ Dysfunction and Recent Surgery – Notice to HospitalsFebruary 3, 2005 · Biologic or vaccine · Product safety
- Updated Safety Information on Hematologic Events Associated with HUMIRA and the Risk of Infections Associated with the Concurrent Use of HUMIRA and Anakinra – Abbott Laboratories, LimitedFebruary 2, 2005 · Biologic or vaccine · New safety information
- Archived - Association of EZETROL® (ezetimibe) with myalgia, rhabdomyolysis, hepatitis, pancreatitis, and thrombocytopenia -Merck Frosst/Schering PharmaceuticalsFebruary 1, 2005 · Drugs
- Archived - Important safety information on HUMIRA (adalimumab) - Abbott Laboratories, LimitedFebruary 1, 2005 · Biologic or vaccine
- Lariam (Mefloquine) – Updated Patient Information – Letter to Pharmacists – Hoffmann-La Roche LimitedJanuary 27, 2005 · Drugs · New safety information
- Lariam (Mefloquine) – Updated Patient Information – For Health ProfessionalsJanuary 27, 2005 · Drugs · New safety information
- Archived – Health Canada Endorsed Important Preliminary Safety Information Regarding REMINYL (Galantamine) – Janssen-Ortho Inc.January 24, 2005 · Drugs · New safety information
- Archived - Important safety information for patients taking Lariam (mefloquine) for the prevention of malaria - Hoffmann-La Roche LimitedJanuary 24, 2005 · Drugs
- Archived - Important safety information for patients taking Apo-Mefloquine (mefloquine) for the prevention of malaria. -Apotex Inc.January 1, 2005 · Drugs
- No title providedJanuary 1, 2005 · Drugs
- AdvisoryJanuary 1, 2005 · Drugs
- AdvisoryJanuary 1, 2005 · Drugs
Natural health products
- Archive – Health Canada Warns Consumers Not to Take Products Containing ChaparralDecember 21, 2005 · Natural health products · Unauthorized product
- Archived - Important safety information on pms-Sodium Phosphates Oral Solution with kidney impairment and nephrocalcinosis - Pharmascience Inc.December 7, 2005 · Natural health products
- Important safety information on Fleet Phospho-Soda (sodium phosphates oral solution) with kidney impairment and nephrocalcinosis - For Health Professionals - MERCK Consumer PharmaceuticalsDecember 2, 2005 · Natural health products
- Archived - Important safety information on Fleet® Phospho-Soda® (sodium phosphates oral solution) with kidney impairment and nephrocalcinosis - Johnson & Johnson - MERCK Consumer PharmaceuticalsDecember 1, 2005 · Natural health products
- Archive – Health Canada Warns Consumers Not to Use Certain Lots of GenTeal Gel Due to Potential Health RiskNovember 18, 2005 · Natural health products · Contamination
- Archive – Health Canada Warns Consumers Not to Take the Chinese Medicine Shortclean Due to Potential Health RiskNovember 17, 2005 · Natural health products
- Archive – Health Canada Advises Consumers Not to Use Certain Herbal Weight Loss Products from ChinaNovember 9, 2005 · Natural health products · Undeclared substance
- Archive – Health Canada Warns Consumers Not to Use GenTeal Artificial Tears Due to Potential Health RiskNovember 5, 2005 · Natural health products · Contamination
- Archive – Health Canada Warns Consumers Not to Take Liqiang 4 Due to Potential Health RiskOctober 25, 2005 · Natural health products · Undeclared substance
- Archive – Health Canada Advises the Canadian Public of Kohl Containing LeadSeptember 28, 2005 · Natural health products
- Archive – Health Canada Warns Consumers Not to Use Sweet-Ease Pacifier DipAugust 11, 2005 · Natural health products · Contamination
- Archive – Health Canada Continues to Warn Consumers Not to Use Miracle II Miracle Neutralizer or Any Other Health Products from Tedco, Inc.August 8, 2005 · Natural health products · Contamination
- Archive – Health Canada Warns Consumers Not to Use Certain Ayurvedic Medicinal ProductsJuly 14, 2005 · Natural health products
- Archive – Health Canada Warns Consumers Not to Use Any Health Products from The Master's MiracleMay 30, 2005 · Natural health products · Contamination
- Archive – Health Canada Warns Consumers Not to Use Any Health Products from Tedco, Inc.May 30, 2005 · Natural health products · Contamination
- Archive - Health Canada Warns Consumers Not to Use The Master's Miracle Fortified Mineral Neutralizer or Miracle II Miracle NeutralizerMay 12, 2005 · Natural health products · Contamination
- Archive – Health Canada Warns Consumers Not to Consume a Certain Lot Number ofPMS-Sodium Polysterene Sulfonate Powder for SuspensionApril 29, 2005 · Natural health products · Dosage - Labelling
- Archive – Health Canada Advises Consumers Not to Use Cough Syrup DM, DIN 02015781, with Lot Numbers Starting with 2J29 and 3J29March 12, 2005 · Drugs - Natural health products · Dosage - Labelling
- Archive – Some Ayurvedic medicinal products reported to contain high levels of heavy metalsMarch 3, 2005 · Natural health products
- Traditional kohl products contain leadJanuary 1, 2005 · Natural health products
Medical devices
- Important Safety Information on Medical Telemetry Systems- Notice to HospitalsDecember 28, 2005 · Medical devices
- Further Information on the Safety of Linvatec Surgical Handpieces Manufactured by ConMed Linvatec, Largo, Florida- Notice to HospitalsDecember 28, 2005 · Medical devices
- Archivé - Important Safety Information on the Interactions between Active Implantable Medical Devices and Systems and other Medical Devices - UpdateDecember 20, 2005 · Medical devices
- Archived - Colleague Volumetric Infusion Pump - Advisories, Warnings and Recalls for Health ProfessionalsDecember 5, 2005 · Medical devices
- Important Safety Information on Medtronic Sigma Series pacemakers- Medtronic of Canada Ltd. - For Health ProfessionalsNovember 30, 2005 · Medical devices
- EclipseNovember 28, 2005 · Medical devices · Type III
- EclipseNovember 28, 2005 · Medical devices · Type III
- Important Safety Information on the market removal of Baxter/Sabratek 6060 Infusion Pumps- Baxter Corporation - For Health ProfessionalsNovember 21, 2005 · Medical devices
- Archive - ACCU-CHEK Aviva Blood Glucose Meter - Advisories, Warnings and Recalls - For the PublicNovember 14, 2005 · Medical devices
- Archive – Potential Safety Risk Regarding the Use of Omron 3-Way Instant ThermometersNovember 10, 2005 · Medical devices
- EclipseNovember 8, 2005 · Medical devices · Type III
- Important Safety Information on the Interactions between Active Implantable Medical Devices and Systems and other Medical Devices - Revision - Notice to HospitalsOctober 31, 2005 · Medical devices
- Important Safety Information on Baxter Infusion Pumps - Notice to HospitalsOctober 25, 2005 · Medical devices
- Important Safety information on certain St. Jude Medical implantable cardiac defibrillators - For Health ProfessionalOctober 6, 2005 · Medical devices
- Important Safety Information on the Interaction between Active Implantable Medical Devices and Systems and other Medical Devices - Notice to HospitalsOctober 5, 2005 · Medical devices
- Important Safety Information on Insignia and Nexus Implantable Pacemakers - Guidant Canada Corporation - For Health ProfessionalsSeptember 22, 2005 · Medical devices
- Important Safety Information on Linvatec Surgical Handpieces Manufactured by ConMed Linvatec, Largo, Florida- Notice to HospitalsSeptember 19, 2005 · Medical devices
- Important Safety Information on Metallic Airway Stents – Notice to HospitalsSeptember 8, 2005 · Medical devices · Medical devices
- Important Safety Information on Proper Preventive Maintenance for Anaesthetic Vaporizers – Notice to HospitalsAugust 12, 2005 · Medical devices · Medical devices
- Important Safety Information on the Recall of Certain Baxter Colleague Volumetric Infusion Pumps – Baxter Corporation – Notice to HospitalsAugust 10, 2005 · Medical devices · Medical devices
- Archive – Health Canada advises Canadians about risks associated with Guidant pacemakersAugust 4, 2005 · Medical devices · Product quality
- Revised safety information on Guidant Implantable Cardiac Defibrillators (VENTAK PRIZM AVT, VITALITY AVT, and CONTAK RENEWAL AVT) – Guidant Canada Corporation – For Health ProfessionalsAugust 3, 2005 · Medical devices · Medical devices
- Important Safety Information on Certain Pacemakers – Guidant Canada Corporation – For Health ProfessionalsJuly 25, 2005 · Medical devices · Product safety
- Important Safety Information on Vail Enclosed Beds - Notice to HospitalsJuly 21, 2005 · Medical devices · Medical devices
- Safety Information on Certain Implantable Cardiac Defibrillators (VENTAK PRIZM AVT, VITALITY AVT and CONTAK RENEWAL AVT) – Guidant Canada Corporation – For Health ProfessionalsJuly 5, 2005 · Medical devices · Product safety
- Safety Information on Certain Implantable Cardiac Defibrillators (Contak Renewal 3 and 4, Renewal 3 and 4 AVT, Renewal RF) – Guidant Canada Corporation – For Health ProfessionalsJune 30, 2005 · Medical devices · Product safety
- Contak Renewal (Model H135) and Contak Renewal 2 (Model H155) Implantable Cardiac Defibrillators – Guidant Canada Corporation –Advisories, Warnings and Recalls for Health ProfessionalsJune 27, 2005 · Medical devices · Product safety
- Safety Information on Certain Guidant Implantable Cardiac Defibrillators – Guidant Canada Corporation – For Health ProfessionalsJune 23, 2005 · Medical devices · Product safety
- Archive – Health Canada Advises Consumers Not to Use New Choice Pregnancy TestMay 13, 2005 · Medical devices · Unauthorized product
- Archived - Important Safety Information on certain LifeScan models of blood glucose monitoring systems. -LifeScanApril 19, 2005 · Medical devices
- Important Notice Concerning Actuator Reliability - Attachment - Notice to HospitalsMarch 31, 2005 · Medical devices
- Important Notice Concerning the Reliability of the Actuator on BHM Ergolifts – Notice to HospitalsMarch 31, 2005 · Medical devices · Product safety
- Archived – Association of Icodextrin-Containing Peritoneal Dialysis Solutions with Falsely Elevated Blood Glucose Monitor Readings – Notice to HospitalsMarch 24, 2005 · Drugs - Medical devices · Product safety
- Archive – Health Canada Advises Diabetic Patients Using Extraneal Peritoneal Dialysis Solution about the Risk of Falsely Elevated Blood Glucose Monitor ReadingsMarch 24, 2005 · Medical devices
- Safety Information on Certain Models of Medtronic Implantable Cardiac Defibrillators – Medtronic of Canada Ltd. – For Health ProfessionalsMarch 22, 2005 · Medical devices · Medical devices
- Risk of Inadvertent Disconnection of Hemodialysis Access Devices – Notice to HospitalsJanuary 19, 2005 · Medical devices · Product safety
- Archived – Entrapment in Beds Due to Inadvertent Activation of Electric Foot SwitchJanuary 12, 2005 · Medical devices · Product safety
- Important Product Recall – Faaborg Lifts – All PL, VL, and Solution/Nordic Series Models – Notice to HospitalsJanuary 12, 2005 · Medical devices · Product safety
- Archived - Important Safety Information on Certain Blood Glucose Monitors - Abbott Diabetes CareJanuary 1, 2005 · Medical devices